A Novel Association between Lysyl Oxidase Gene Polymorphism and Intracranial Aneurysm in Koreans

Eun Pyo Hong; Jin Pyeong Jeon; Sung-Eun Kim; Jin Seo Yang; Hyuk Jai Choi; Suk Hyung Kang; Yong Jun Cho

doi:10.3349/ymj.2017.58.5.1006

Journal List > Yonsei Med J > v.58(5) > 1032044

Go to TopGo to Top Go to BottomGo to Bottom

TOOLS

Hong, Jeon, Kim, Yang, Choi, Kang, and Cho: A Novel Association between Lysyl Oxidase Gene Polymorphism and Intracranial Aneurysm in Koreans

Original Article

Neurology & Neurosciences

Yonsei Medical Journal 2017; 58(5): 1006-1011.

Published online: 31 July 2017

DOI: https://doi.org/10.3349/ymj.2017.58.5.1006

A Novel Association between Lysyl Oxidase Gene Polymorphism and Intracranial Aneurysm in Koreans

Eun Pyo Hong¹, Jin Pyeong Jeon^2,³, Sung-Eun Kim⁴, Jin Seo Yang², Hyuk Jai Choi², Suk Hyung Kang², Yong Jun Cho²

¹Department of Medical Genetics, Hallym University College of Medicine, Chuncheon, Korea.

²Department of Neurosurgery, Hallym University College of Medicine, Chuncheon, Korea.

³Institute of New Frontier Research, Hallym University College of Medicine, Chuncheon, Korea.

⁴Department of Emergency Medicine, Seoul Emergency Operations Center, Seoul, Korea.

Corresponding author: Dr. Jin Pyeong Jeon, Department of Neurosurgery, Hallym University College of Medicine, 77 Sakju-ro, Chuncheon 24253, Korea. Tel: 82-33-240-5171, Fax: 82-33-240-9970, jjs6553@daum.net

Received 10 May 2017 Revised 17 June 2017 Accepted 27 June 2017

(open-access, http://creativecommons.org/licenses/by-nc/4.0/):

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Purpose

Lysyl oxidase (LOX) controls the cross-linking and maturation of elastin and collagen fibers. In this study, we investigated the association between LOX gene polymorphisms and intracranial aneurysm (IA) formation in a homogeneous Korean population.

Materials and Methods

This cross-sectional study involved 80 age-sex matched patients with IA and controls. Fisher's exact test was performed to analyze allelic associations between ten single nucleotide polymorphisms (SNPs) and IA, including 41 ruptured and 39 unruptured cases. Haplotype-specific associations were analyzed using the omnibus test estimating asymptotic chi-square statistics.

Results

Of ten SNPs, three SNPs (rs2303656, rs3900446, and rs763497) were significantly associated with IA (p<0.01). The C allele of rs3900446 was significantly related to increased IA risk with a significant threshold [odds ratio (OR)=20.15, p=4.8×10⁻⁵]. Meanwhile, the A allele of rs2303656 showed a preventive effect against IA formation (p=8.2×10⁻⁴). Seventeen of 247 haplotype structures showed a suggestive association with IA (asymptotic p<0.001). Of ten SNP haplotype combinations, the CG combination of rs3900446 and rs763497 reached Bonferroni-adjusted significant threshold in IA patients (minor haplotype frequency=0.113, asymptotic p=1.3×10⁻⁵). However, there was no association between aneurysm rupture and the LOX gene.

Conclusion

This preliminary study indicated that LOX gene polymorphisms, such as rs2303656, rs3900446, and rs763497, may play crucial roles in IA formation in the Korean population. Our novel findings need to be validated in a large-scale independent population.

Keywords: Intracranial aneurysm, subarachnoid hemorrhage, lysyl oxidase, SNP

INTRODUCTION

Intracranial aneurysm (IA) accounts for approximately 85% of all subarachnoid hemorrhages (SAHs), which have a high mortality rate of up to 50%.1 Extracellular matrix (ECM) provides structural integrity to the arterial wall, and disruption of the ECM may be related to IA formation.2 Lysyl oxidase (LOX) is a copper-containing amine oxidase that regulates cross-linking and maturation of collagen and elastin.3 4 Accordingly, the LOX gene has been investigated as a candidate for IA development.4 Mäki, et al.5 reported that inactivation of the LOX gene led to aortic aneurysm caused by structural alteration in the arterial wall in mice. Onda, et al.6 found three linkage regions of IA, chromosome 5q22-31, 7q11 and 14q22, in Japanese sib pairs.6 However, LOX mapped to 5q31 did not show allelic and haplotype-based association with IA in the Japanese population. In addition, no significant associations of LOX variants with IA were observed in a South Indian population.7 Nevertheless, LOX has been reported to be a risk factor for coronary artery disease (CAD) and cerebral stroke. Ma, et al.8 found that G473A polymorphism of LOX was associated with CAD. Zhang, et al.9 reported that frequencies of LOX 473AA genotype and an A allele were significantly higher in patients with ischemic stroke, compared to controls, in a Chinese population. A missense mutation of LOX (c.893T>G encoding p.Met298Arg) was also associated with thoracic aortic aneurysm in humans.10 Such data suggest that LOX variants could be related to IA formation by degenerative endothelial remodeling due to insufficient cross-linking of elastin and collagen fibers in the region of high wall share stress or high spatial pressure gradients.11 12

To the best of our knowledge, up to now, a genetic association study of LOX gene polymorphisms has not been conducted in Koreans. Therefore, in an attempt to assess genetic risks in affected IA patients, we aimed to identify LOX gene polymorphisms giving rise to susceptibility to IA in a homogeneous Korean population.

MATERIALS AND METHODS

Study population

This prospective study included 80 radiologically confirmed IA patients with saccular shape, as well as 80 age-and sex-matched controls, from March to December 2016 at a single institution. Non-saccular aneurysms featuring fusiform or dissection and traumatic or infectious aneurysms were excluded. The control group consisted of matched patients who underwent computed tomography or magnetic resonance angiography for headache evaluation or a medical check-up, excluding other neurological diseases, such as arteriovenous malformation, intracranial hemorrhage or infarct, etc. Medical records were reviewed concerning multiple variables, such as sex, age, clinical presentation such as unruptured IA or SAH, hypertension (HTN), diabetes mellitus (DM), hyperlipidemia, smoking,13 and familial history of aneurysm (vs. sporadic). Angiographic variables were reviewed regarding the size of the aneurysm, location (anterior vs. posterior circulation),14 and number (single vs. multiple). This study was approved by the Institutional Review Boards (No. 2016-31).

SNP selection and genotyping

We selected 10 tagging single nucleotide polymorphisms (SNPs) located between 20 kb 5′-upstream and 3′-downstream of the LOX gene after applying a linkage disequilibrium (LD; r²<0.8) in Japanese and Chinese (JPT+CHB) HapMap database (Phase II) from the LD TAG SNP Selection (TagSNP) of SNPinfo (https://snpinfo.niehs.nih.gov/). For genotyping of 10-tagged SNPs, genomic DNA from the peripheral blood of all 160 subjects was extracted using HiGene™ Genomic DNA Prep Kit (BIOFACT, Daejeon, Korea). Primers of ten SNPs were designed using the Primer-3 v.0.4.0 program (http://bioinfo.ut.ee/primer3-0.4.0/) (Table 1). Polymerase chain reaction (PCR) was performed at 25-uL volume containing 100 ng genomic DNA with 1.5 uL per primer (10 pmole/uL) by Solg™ 2X Taq PCR Pre-Mix (Solgent, Daejeon, Korea). Pre-denaturation was done at 95℃ for 5 minutes, 34 cycles of denaturation at 95℃ for 30 seconds, annealing at 63℃ for 30 seconds, extension at 72℃ for 1 minute, and a final extension at 72℃ for 5 minutes. The amplified fragments were confirmed by 1.5% agarose gel electrophoresis, purified with the Solg™ PCR purification kit (SolGent, Daejeon, Korea), and sequenced by the ABI PRISM 3730XL Analyzer (Applied Biosystems, Foster City, CA, USA).

Statistical analyses

Continuous data are expressed as means±standard deviation. Kruskal-Wallis test with descriptive analysis was conducted to evaluate the difference between 80 IA patients and 80 controls for non-genetic factors. Fisher's exact test was performed to assess allelic associations between IA and ten SNPs located near or on the LOX gene to estimate odds ratios (ORs). In subsequent analysis, we analyzed the genetic effects of the LOX gene on IA formation according to aneurysm rupture. Furthermore, an omnibus test with haplotype-specific association analysis, which contains h-1 degrees of freedom (h, the number of all possible haplotypes in a sliding window depending on the number of SNPs), was conducted using asymptotic chi-square statistics to identify significant haplotype associations with IA. This test excluded haplotype structures with a minor haplotype frequency (MHF) less than 0.01 of possible combinations using ten SNPs. We applied Bonferroni-adjusted significant p value less than 0.005 and 2.0×10⁻⁴ after testing multiple comparison corrections and suggestive significant p values of 0.01 and 0.001 in single SNPs and haplotype associations, respectively. The descriptive and univariate analyses were performed by STATA software v.11.2 (Stata Corp., College Station, TX, USA). Quality control test for 10 SNPs was conducted to evaluate the genotyping call rate (GCR), minor allele frequency (MAF), Hardy Weinberg equilibrium (HWE) p value, and pairwise LD using Haploview v.4.2 (https://www.broadinstitute.org/haploview/haploview).15 Genetic and haplotype associations were analyzed using PLINK program v.1.07 (http://zzz.bwh.harvard.edu/plink/).16

RESULTS

Demographic characteristics of the enrolled patients

The baseline characteristics of the two groups (IA and controls) are described in Table 2 and Supplementary Table 1 (only online). In the IA group, the number of females was 43 (53.8%), and their mean age was 57.1±12.9 years. SAH presentation was noted for 41 (51.3%) patients. Regarding aneurysm location, anterior circulation aneurysms (n=73, 91.3%) were noted as follows: internal carotid artery, n=15; anterior communicating artery or anterior cerebral artery, n=21; middle cerebral artery, n=25; and posterior communicating artery, n=12. Seventy-five (93.8%) patients had a single aneurysm. No patient who had a familial history of SAH was observed in our study. Between the two groups, the incidences of HTN, DM, hyperlipidemia, and smoking did not differ significantly.

Genetic associations of 10 LOX gene polymorphisms with IA

All ten SNPs located near or on the LOX gene showed completed GCR, MAF greater than 0.01, HWE p-value greater than 0.05, and LD greater than 0.8 after quality control tests. The LD structures of ten SNPs in patients with IA, the control group, and all subjects are shown in Fig. 1. There remained LD in rs10040971 with rs3792801 (r²=1.00) and rs10519694 with rs3853401 (r²=0.89) in patients with IA and rs2956540 with rs1800449 in controls. Among ten SNPs, three SNPs, rs2303656, rs3900446, and rs763497, showed statistically significant associations with IA (p<0.05) (Table 3) (Supplementary Table 2, only online). Two SNPs, rs2303656 and rs3900446, reached the Bonferroni-adjusted significance threshold (p<0.005). The C allele of rs3900446 showed the most significant and strongest associations with an increased risk of IA (OR=20.15, p=4.8×10⁻⁵). On the contrary, the A allele of rs2303656 showed a protective effect on IA and was not frequently observed in the patient group (p=8.2×10⁻⁴). The G allele of rs763497 showed a suggestive association with an increased IA risk (OR=2.26, p=0.009). However, none of the SNPs was associated with IA rupture among 80 patients with IA in subsequent analysis (p>0.05).

In an omnibus test of haplotype association, 136 of total 247 haplotype structures in 45 sliding windows (SNP set) showed an asymptotic p-value less than 0.05 (data not shown), and 17 haplotypes showed a suggestive association with IA (asymptotic p<0.001) (Table 4). Of ten SNP haplotype combinations, the CG combination of rs3900446 and rs763497 showed significant associations in a single SNP analysis (MHF=0.113, asymptotic p=1.3×10⁻⁵) (Table 3). Although six SNPs (rs10040971, rs17148773, rs3792801, rs10519694, rs2956540, and rs1800449) were not independently associated in single SNP analyses, the haplotype structures of combining these SNPs with either rs2303656, rs3900446, or rs763497 were significant in haplotype analyses (6.5×10⁻⁴<p<7.5×10⁻⁴) (Table 4).

DISCUSSION

Our results showed that three SNPs (rs2303656, rs3900446, and rs763497) were significantly associated with IA in a Korean population. The T allele of rs3900446 was significantly related to an increased IA risk with a significant threshold (OR=20.15, p=4.8×10⁻⁵). On the contrary, the A allele of rs2303656 revealed the protective effect on IA formation. Haplotype analysis showed that the CG combination of rs3900446 and rs763497 reached Bonferroni-adjusted significant threshold in IA patients (MHF=0.113, asymptotic p=1.3×10⁻⁵).

Aneurysms featured multifactorial disorder affected by environmental and genomic factors. Variables, such as HTN, smoking and larger size at diagnosis, have been reported to be associated with IA formation and growth.17 Subjects with first-degree IA relatives showed four times higher incidence of aneurysm, compared to those without IA relatives.18 Compared to sporadic aneurysms, familial aneurysms showed larger size of aneurysm at the time of rupture and multiplicity.19 After reviewing 10 genome-wide linkage analyses of familial IA, four loci, such as 1p34.3-p36.13, 7q11, 19q13.3, and Xp22, were demonstrated in other cohorts.20 Positional and functional candidate genes of elastin and collagen type 1 A2 were associated with 7q11 and perlecan with 1p34.3-p36.13. Regarding sporadic IA, SNPs on chromosome 4 near the endothelin receptor A gene (rs6841581), chromosome 9 within the cyclin-dependent kinase inhibitor 2B antisense inhibitor gene (rs10757278 and rs1333040), and chromosome 8 near the SOX17 transcription regulator gene (rs9298506 and rs10958409) were significantly associated with aneurysm.21 Beyond the suggestive loci for IA as mentioned above, versican (VCAN) gene located at the locus of 5q22-31 has been reported to be related to IA. Two SNPs rs251124 and rs173686 in strong LD and haplotypes were associated with IA in a Dutch population.22 Sathyan, et al.23 reported that rs251124 was the strongest marker of IA for global ethnicities. In addition, a novel association of IA with rs2287926 (G428D) in exon 7 coding has been reported. Other potential candidate genes, such as LOX, fibroblast growth factor 1 (FGF1) and fibrillin 2 (FBN2), can be included in the linkage region of 5q22-31. Yoneyama, et al.24 reported difference in allelic frequency for SNP at intron 4 of FGF1 (χ²=4.44, df=1, p=0.035); however, no association of SNP in LOX or FBN2 was noted. Hofer, et al.4 also did not find an allelic association or co-segregation in 25 German IA families after analyzing four genetic variants. Ruigrok, et al.25 analyzed the 44 potential candidate genes of ECM integrity in a Dutch population in developing IA. They reported that serpine 1 (SERPINE 1, combined OR 1.27, p=0.004), FBN2 (combined OR 1.37, p=0.01), and alpha 1 type IV collagen (COL4A1, combined OR 1.22, p=0.007) were related to IA; however, no association of SNPs between the LOX gene and IA was demonstrated. Sathyan, et al.7 did not find allelic or genotypic variants of the LOX gene in a South Indian population with IA. Several genome-wide association studies26 27 also did not demonstrate the 5q22-31 loci for IA formation. In contrast, three SNPs (rs2303656, rs3900446, and rs763497) were significantly associated with IA in Koreans in this study. Differences in the frequencies of genetic polymorphisms according to ethnics have been reported. Tian, et al.28 reported the genetic diversity of many SNPs in cancer-related genes between Chinese Hui and Han populations. Inoue, et al.29 also showed a difference in the frequency distribution of the genetic polymorphisms in the CYP1A1 and CYP1B1 gene in Japanese and Caucasian populations. Accordingly, ethnic differences should be carefully considered in evaluating risk factors for the disease.30

Hemodynamic factors have been thought to be related to aneurysm formation. The fluid dynamic study revealed that elevated wall share stress by repetitive flow impingement may contribute to aneurysm formation by degenerative endothelial remodeling.11 12 In clinical circumstances, most aneurysms were located at the arterial branching and bifurcation sites. Alterations in the aneurysm wall and, in particular, focal degradation of the ECM have been linked to aneurysm formation and growth.31 Bruno, et al.31 reported that aneurysm tissue showed a higher level of membrane-type matrix metalloproteinase (MMP) and MMP-2, compared to controls. LOX controls the cross-linking and maturation of elastin and collagen fibers, which are responsible for mechanical stability of the arterial wall.4 Accordingly, LOX gene variants could lead to ECM instability and aneurysm formation by inducing insufficient stability to mechanical stimuli on the arterial wall.

There are some limitations in this study. First, the sample size was relatively small, although LOX gene polymorphisms were observed to have strong associations with IA and likely to imply a sufficient statistical power due to its large effect size.32 The second GWAS by Yasuno, et al.33 showed additional three new loci near retinoblastoma binding protein 8 (RBBP8) on 18q11.2, StAR-related lipid transfer domain containing 13/Klotho (STARD13/KL) on 13q13.1, and a gene-rich region on 10q24.32, as well as prior associations near SOX17 and CDKN2A/B. However, the LOX gene was not associated with IA in their study. One possible explanation for missed loci is that two SNPs of rs2303656 and rs3900446 are rare variants in Europeans or Japanese than Koreans. However, small sample size could also affect the high risk of C allele of rs3900446 for IA formation. Second, no replication for the associations between LOX gene polymorphisms and IA was performed. Third, supportive functional data was not provided. Accordingly, our novel findings should be replicated in other populations via further studies including in silico functional studies. Nevertheless, this study is the first genetic association study of LOX gene polymorphisms and IA in Koreans.

In conclusion, this preliminary study showed that three SNPs (rs2303656, rs3900446, and rs763497) were significantly associated with aneurysm formation in Koreans. The C allele of rs3900446 was identified to be strongly associated with an increased risk of IA, while the A allele of rs2303656 showed a protective effect on IA formation. According to haplotype analysis, the CG combination of rs3900446 and rs763497 may contribute to an increased risk of IA. Our findings may play crucial roles in understanding the pathogenesis of IA and provide information on improving genetic risk prediction of IA.

ACKNOWLEDGEMENTS

This research was supported by the Hallym University Research Fund 2015 (HURF-2015-15) and a National Research Foundation of Korea grant funded by the Ministry of Science, Information and Communication Technologies and Future Planning of the Korea Government (No. 2017M3A9E8033223). All authors declare no competing interests.

Notes

The authors have no financial conflicts of interest.

References

1. Schievink WI, Wijdicks EF, Parisi JE, Piepgras DG, Whisnant JP. Sudden death from aneurysmal subarachnoid hemorrhage. Neurology. 1995; 45:871–874. PMID: 7746399.

2. Ruigrok YM, Rinkel GJ, Wijmenga C. Genetics of intracranial aneurysms. Lancet Neurol. 2005; 4:179–189. PMID: 15721828.

3. Myllyharju J, Kivirikko KI. Collagens and collagen-related diseases. Ann Med. 2001; 33:7–21. PMID: 11310942.

4. Hofer A, Ozkan S, Hermans M, Kubassek N, Sitzer M, Burtscher J, et al. Mutations in the lysyl oxidase gene not associated with intracranial aneurysm in central European families. Cerebrovasc Dis. 2004; 18:189–193. PMID: 15273433.

5. Mäki JM, Räsänen J, Tikkanen H, Sormunen R, Mäkikallio K, Kivirikko KI, et al. Inactivation of the lysyl oxidase gene Lox leads to aortic aneurysms, cardiovascular dysfunction, and perinatal death in mice. Circulation. 2002; 106:2503–2509. PMID: 12417550.

6. Onda H, Kasuya H, Yoneyama T, Takakura K, Hori T, Takeda J, et al. Genomewide-linkage and haplotype-association studies map intracranial aneurysm to chromosome 7q11. Am J Hum Genet. 2001; 69:804–819. PMID: 11536080.

7. Sathyan S, Koshy L, Sarada Lekshmi KR, Easwer HV, Premkumar S, Alapatt JP, et al. Lack of association of lysyl oxidase (LOX) gene polymorphisms with intracranial aneurysm in a south Indian population. Mol Biol Rep. 2013; 40:5869–5874. PMID: 24065528.

8. Ma L, Song H, Zhang M, Zhang D. Lysyl oxidase G473A polymorphism is associated with increased risk of coronary artery diseases. DNA Cell Biol. 2011; 30:1033–1037. PMID: 21612403.

9. Zhang HF, Zhao KJ, Xu Y, Hong B, Zhao WY, Liu JM, et al. Lysyl oxidase polymorphisms and ischemic stroke--a case control study. Mol Biol Rep. 2012; 39:9391–9397. PMID: 22722997.

10. Lee VS, Halabi CM, Hoffman EP, Carmichael N, Leshchiner I, Lian CG, et al. Loss of function mutation in LOX causes thoracic aortic aneurysm and dissection in humans. Proc Natl Acad Sci U S A. 2016; 113:8759–8764. PMID: 27432961.

11. Jeong W, Rhee K. Hemodynamics of cerebral aneurysms: computational analyses of aneurysm progress and treatment. Comput Math Methods Med. 2012; 2012:782801. PMID: 22454695.

12. Hoi Y, Meng H, Woodward SH, Bendok BR, Hanel RA, Guterman LR, et al. Effects of arterial geometry on aneurysm growth: three-dimensional computational fluid dynamics study. J Neurosurg. 2004; 101:676–681. PMID: 15481725.

13. Jeon JP, Cho YD, Rhim JK, Yoo DH, Kang HS, Kim JE, et al. Extended monitoring of coiled aneurysms completely occluded at 6-month follow-up: late recanalization rate and related risk factors. Eur Radiol. 2016; 26:3319–3326. PMID: 26747259.

14. Cho YD, Jeon JP, Rhim JK, Park JJ, Yoo RE, Kang HS, et al. Progressive thrombosis of small saccular aneurysms filled with contrast immediately after coil embolization: analysis of related factors and long-term follow-up. Neuroradiology. 2015; 57:615–623. PMID: 25808124.

15. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005; 21:263–265. PMID: 15297300.

16. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007; 81:559–575. PMID: 17701901.

17. Jeon JS, Ahn JH, Huh W, Son YJ, Bang JS, Kang HS, et al. A retrospective analysis on the natural history of incidental small paraclinoid unruptured aneurysm. J Neurol Neurosurg Psychiatry. 2014; 85:289–294. PMID: 23781005.

18. Schievink WI, Schaid DJ, Michels VV, Piepgras DG. Familial aneurysmal subarachnoid hemorrhage: a community-based study. J Neurosurg. 1995; 83:426–429. PMID: 7666217.

19. Ruigrok YM, Rinkel GJ, Algra A, Raaymakers TW, Van Gijn J. Characteristics of intracranial aneurysms in patients with familial subarachnoid hemorrhage. Neurology. 2004; 62:891–894. PMID: 15037688.

20. Ruigrok YM, Rinkel GJ. Genetics of intracranial aneurysms. Stroke. 2008; 39:1049–1055. PMID: 18258833.

21. Alg VS, Sofat R, Houlden H, Werring DJ. Genetic risk factors for intracranial aneurysms: a meta-analysis in more than 116,000 individuals. Neurology. 2013; 80:2154–2165. PMID: 23733552.

22. Ruigrok YM, Rinkel GJ, Wijmenga C. The versican gene and the risk of intracranial aneurysms. Stroke. 2006; 37:2372–2374. PMID: 16917090.

23. Sathyan S, Koshy LV, Balan S, Easwer HV, Premkumar S, Nair S, et al. Association of Versican (VCAN) gene polymorphisms rs251124 and rs2287926 (G428D), with intracranial aneurysm. Meta Gene. 2014; 2:651–660. PMID: 25606449.

24. Yoneyama T, Kasuya H, Onda H, Akagawa H, Jinnai N, Nakajima T, et al. Association of positional and functional candidate genes FGF1, FBN2, and LOX on 5q31 with intracranial aneurysm. J Hum Genet. 2003; 48:309–314. PMID: 12750963.

25. Ruigrok YM, Rinkel GJ, van’t Slot R, Wolfs M, Tang S, Wijmenga C. Evidence in favor of the contribution of genes involved in the maintenance of the extracellular matrix of the arterial wall to the development of intracranial aneurysms. Hum Mol Genet. 2006; 15:3361–3368. PMID: 17038484.

26. Akiyama K, Narita A, Nakaoka H, Cui T, Takahashi T, Yasuno K, et al. Genome-wide association study to identify genetic variants present in Japanese patients harboring intracranial aneurysms. J Hum Genet. 2010; 55:656–661. PMID: 20613766.

27. Bilguvar K, Yasuno K, Niemelä M, Ruigrok YM, von Und Zu Fraunberg M, van Duijn CM, et al. Susceptibility loci for intracranial aneurysm in European and Japanese populations. Nat Genet. 2008; 40:1472–1477. PMID: 18997786.

28. Tian C, Chen Z, Ma X, Yang M, Wang Z, Dong Y, et al. Comparison of genetic variants in cancer-related genes between chinese Hui and Han populations. PLoS One. 2015; 10:e0145170. PMID: 26683024.

29. Inoue K, Asao T, Shimada T. Ethnic-related differences in the frequency distribution of genetic polymorphisms in the CYP1A1 and CYP1B1 genes in Japanese and Caucasian populations. Xenobiotica. 2000; 30:285–295. PMID: 10752643.

30. Joo SP, Lee JK, Kim TS, Kim MK, Lee IK, Seo BR, et al. A polymorphic variant of the endoglin gene is associated with increased risk for intracranial aneurysms in a Korean population. Surg Neurol. 2008; 70:39–44. PMID: 18440621.

31. Bruno G, Todor R, Lewis I, Chyatte D. Vascular extracellular matrix remodeling in cerebral aneurysms. J Neurosurg. 1998; 89:431–440. PMID: 9724118.

32. Hong EP, Park JW. Sample size and statistical power calculation in genetic association studies. Genomics Inform. 2012; 10:117–122. PMID: 23105939.

33. Yasuno K, Bilguvar K, Bijlenga P, Low SK, Krischek B, Auburger G, et al. Genome-wide association study of intracranial aneurysm identifies three new risk loci. Nat Genet. 2010; 42:420–425. PMID: 20364137.

Supplementary Material

Supplementary Table 1

Baseline Characteristics and Association Results between IA and Non-Genetic Factors

ymj-58-1006-s001.pdf

Supplementary Table 2

Results of 10 SNP Associations with IA under the Additive Genetic Model after Adjustment of Age, Sex, Smoking, and Three Disease Status Shown in Supplementary Table 1

ymj-58-1006-s002.pdf

Fig. 1

Linkage disequilibrium patterns of 10 Lysyl oxidase SNPs in patients with intracranial aneurysm (A), controls (B), and total groups (C). SNPs, single nucleotide polymorphisms.

Table 1

Primers Designed for 10 SNPs of the Lysyl Oxidase Gene

SNP	Primer	Primer sequence	Length
rs10040971	Forward	5'-CTACCTCCCCAAGTGTTGCT-3'	597 bp
rs10040971	Reverse	5'-AGCTCAGGGCATCAACAAAC-3'	597 bp
rs17148773, rs3792801	Forward	5'-AGCCTTGAAGTCTGGGGAAT-3'	689 bp
rs17148773, rs3792801	Reverse	5'-AGGCAGAAACTGGACCAAAG-3'	689 bp
rs2303656	Forward	5'-TGGCTGTTATGATACCTATGGTG-3'	500 bp
rs2303656	Reverse	5'-CGCATGATGTCCTGTGTAGC-3'	500 bp
rs10519694	Forward	5'-TTGGGTGACCAAAGTGATCTT-3'	543 bp
rs10519694	Reverse	5'-CATGAGGGGCTATTATCTCCA-3'	543 bp
rs1800449	Forward	5'-GATCCAATGGGAGAACAACG-3'	700 bp
rs1800449	Reverse	5'-GGACTGCAAAGCAATGTGAA-3'	700 bp
rs2956540	Forward	5'-CACAGGTCAGTGTGGGTCCT-3'	499 bp
rs2956540	Reverse	5'-CTGGGCGGGAGTCAAATTAT-3'	499 bp
rs3853401	Forward	5'-GCTTTGTATGAGCTTCTTGAGC-3'	692 bp
rs3853401	Reverse	5'-CCCTTTGTCACACATGCTAATG-3'	692 bp
rs3900446, rs763497	Forward	5'-TTGAGAGTCTGTTGAGAATGGA-3'	809 bp
rs3900446, rs763497	Reverse	5'-CATGCAACCTAAATCCCTCAT-3'	809 bp

SNP, single nucleotide polymorphism.

Table 2

Baseline Characteristics of Patients with IA and Controls

Variables	IA (n=80)	Controls (n=80)	p value
Female (%)	43 (53.8)	45 (56.3)	0.751
Age (yr)	57.1±12.9	55.9±15.3	0.424
Hypertension (%)	17 (21.3)	14 (17.5)	0.550
Diabetes mellitus (%)	6 (7.5)	7 (8.8)	0.777
Hyperlipidemia (%)	8 (10.0)	6 (7.5)	0.577
Smoking (%)	8 (10.0)	6 (7.5)	0.577
Anterior circulating aneurysm (%)	73 (91.3)
ICA/A-com or ACA	15/21
MCA/P-com	25/12

ICA, internal carotid artery; A-com, anterior communicating artery; ACA, anterior cerebral artery; MCA, middle cerebral artery; P-com, posterior communicating artery; IA, intracranial aneurysm.

Table 3

Results of 10 SNPs Associations with IA

Gene Chr.	SNP	Position	Function		M/m^*	80 patients with IA and 80 controls				41 IA rupture and 39 non-rupture in 80 patients
Gene Chr.	SNP	Position	Class	Effect	M/m^*	MAF^†	HWE p^‡	OR^§	p value^§	MAF^†	OR^§	p value^§
LOX 5q23.2	rs10040971	122063842	Intron	None	T/C	0.04/0.03	1.00	1.42	0.770	0.06/0.03	2.47	0.444
	rs17148773	122067364	Intron	None	C/T	0.00/0.03	1.00	0.00	0.061	0.00/0.00	NA	1.000
	rs3792801	122067715	Intron	None	C/T	0.04/0.10	1.00	0.41	0.081	0.06/0.03	2.47	0.444
	rs2303656	122070281	Intron	None	C/A	0.00/0.07	1.00	0.00	8.2×10⁻⁴	0.00/0.00	NA	1.000
	rs10519694	122071524	Intron	None	C/T	0.06/0.03	1.00	2.60	0.170	0.05/0.08	0.62	0.527
	rs2956540	122073485	Intron	None	C/G	0.24/0.19	0.73	1.40	0.277	0.24/0.24	1.00	1.000
	rs1800449	122077513	R158Q	Benign	G/A	0.15/0.18	1.00	0.83	0.650	0.16/0.14	1.15	0.827
	rs3853401	122081992	5−4 kb	None	C/T	0.06/0.07	1.00	0.81	0.818	0.04/0.08	0.46	0.320
	rs3900446	122090980	5−13 kb	None	T/C	0.11/0.01	1.00	20.15	4.8×10⁻⁵	0.07/0.15	0.43	0.135
	rs763497	122091535	5−13 kb	None	A/G	0.24/0.13	1.00	2.26	0.009	0.22/0.27	0.76	0.581

Chr., chromosome; IA, intracranial aneurysm; NA, not available; OR, odds ratio; MAF, minor allele frequency; HWE, Hardy-Weinberg equilibrium; SNPs, single nucleotide polymorphisms.

^*Major/minor allele type, ^†MAF in case (left) and control (right) groups, ^‡HWE p-value for control group, ^§OR and p value were estimated from allelic association analysis using Fisher's exact test.

Table 4

Results of Haplotype Associations with Intracranial Aneurysm

SNPset	Haplotype	MHF^*	Chi-square^†	p_asym^†
rs3792801-rs2303656	TA	0.000/0.069	11.39	7.4×10⁻⁴
rs2303656-rs10519694	AC	0.000/0.069	11.39	7.4×10⁻⁴
rs3853401-rs3900446	TT	0.000/0.069	11.39	7.4×10⁻⁴
rs3900446-rs763497	CG	0.113/0.000	18.96	1.3×10⁻⁵
rs10040971-rs17148773-rs3792801	TCT	0.000/0.069	11.39	7.4×10⁻⁴
rs17148773-rs3792801-rs2303656	CTA	0.000/0.069	11.39	7.4×10⁻⁴
rs3792801-rs2303656-rs10519694	TAC	0.000/0.069	11.39	7.4×10⁻⁴
rs2303656-rs10519694-rs2956540	ACG	0.000/0.070	11.52	6.9×10⁻⁴
rs10040971-rs17148773-rs3792801-rs2303656	TCTA	0.000/0.069	11.39	7.4×10⁻⁴
rs17148773-rs3792801-rs2303656-rs10519694	CTAC	0.000/0.069	11.39	7.4×10⁻⁴
rs3792801-rs2303656-rs10519694-rs2956540	TACG	0.000/0.070	11.52	6.9×10⁻⁴
rs2303656-rs10519694-rs2956540-rs1800449	ACGA	0.000/0.070	11.54	6.8×10⁻⁴
rs10040971-rs17148773-rs3792801-rs2303656-rs10519694	TCTAC	0.000/0.069	11.39	7.4×10⁻⁴
rs17148773-rs3792801-rs2303656-rs10519694-rs2956540	CTACG	0.000/0.070	11.52	6.9×10⁻⁴
rs3792801-rs2303656-rs10519694-rs2956540-rs1800449	TACGA	0.000/0.070	11.54	6.8×10⁻⁴
rs10040971-rs17148773-rs3792801-rs2303656-rs10519694-rs2956540	TCTACG	0.000/0.070	11.52	6.9×10⁻⁴
rs17148773-rs3792801-rs2303656-rs10519694-rs2956540-rs1800449	CTACGA	0.000/0.070	11.54	6.8×10⁻⁴
rs10040971-rs17148773-rs3792801-rs2303656-rs10519694-rs2956540-rs1800449	TCTACGA	0.000/0.070	11.54	6.8×10⁻⁴

MHF, minor haplotype frequency; SNP, single nucleotide polymorphism.

^*MHF of case (left) and control (right), ^†Asymptotic chi-square statistics and p value were estimated by the omnibus-based haplotype association test.

TOOLS

Similar articles